Freedom Investment Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Freedom Investment Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5,801	Closed	-$667K	–	724
2019 Q3	$667K	Sell	5,801 -73	-1%	-$11.1K	0.06%	292
2019 Q2	$1.01M	Sell	5,874 -236	-4%	-$40.8K	0.08%	219
2019 Q1	$1.03M	Buy	6,110 +1,316	+27%	+$196K	0.08%	228
2018 Q4	$467K	Sell	4,794 -67	-1%	-$8.79K	0.04%	442
2018 Q3	$696K	Buy	4,861 +2	+0%	+$288	0.04%	416
2018 Q2	$678K	Buy	4,859 +750	+18%	+$107K	0.04%	439
2018 Q1	$463K	Buy	4,109 +318	+8%	+$40K	0.02%	658
2017 Q4	$500K	Buy	3,791 +424	+13%	+$49.8K	0.03%	629
2017 Q3	$342K	Buy	3,367 +468	+16%	+$50.1K	0.02%	780
2017 Q2	$291K	Buy	2,899 +547	+23%	+$58.9K	0.02%	800
2017 Q1	$284K	Buy	+2,352	New	+$289K	0.02%	804

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MGIM

M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Freedom Investment Management's GWPH Position: Q4 2019 in Review

Freedom Investment Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2019, closing a stake of 5,801 shares — an estimated $667K sold.

Freedom Investment Management first reported a position in GWPH in Q1 2017 and held it in 11 quarters. The position peaked at $1.03M in Q1 2019. 318 funds tracked by Wall St. Rank hold GWPH as of Q4 2019.

Freedom Investment Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2019 after selling out during the quarter.
Freedom Investment Management sold 5,801 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2019, an estimated $667K.
Freedom Investment Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2017 and held it in 11 quarters.
Freedom Investment Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.03M in Q1 2019.
318 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2019.

Based on Freedom Investment Management's 13F filing for Q4 2019, filed 24 Jan 2020.